PulmonologyNews.net

Pulmonology Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Medical Meeting

Search results for "Spiriva"

Boehringer Ingelheim has informed the FDA ( Food and Drug Administration ) that ongoing safety monitoring has identified a possible increased risk of stroke in patients who take this Spiriva HandiHale ...


Researchers have compared the efficacy and safety of Indacaterol ( Arcapta Neohaler, Onbrez Breezhaler ) and Tiotropium ( Spiriva ) in patients with severe chronic obstructive pulmonary disease ( COPD ...


Two once-daily long-acting muscarinic antagonists ( LAMAs ) are currently available for the treatment of chronic obstructive pulmonary disease ( COPD ), Tiotropium ( Spiriva ) and Glycopyrronium ( See ...


Glycopyrronium ( Seebri Breezhaler ) is a once daily long-acting muscarinic antagonist that is approved for maintenance treatment of COPD ( chronic obstructive pulmonary disease ). This post-hoc poole ...


Inhaled Glycopyrronium bromide ( Seebri Breezhaler; NVA237 ) is a once-daily, long-acting muscarinic receptor antagonist ( LAMA ) that is approved in several countries, as a maintenance bronchodilator ...


Combination long-acting bronchodilator treatment might be more effective than long-acting bronchodilator monotherapy for the treatment of chronic obstructive pulmonary disease ( COPD ). A study has c ...


Despite currently available therapies and detailed guidelines, many people with mild asthma remain symptomatic; it is important to establish the efficacy and safety of new treatments in this group. ...


In patients with symptomatic asthma receiving ICS or ICS+LABA, phase III studies have demonstrated improved lung function with Tiotropium ( Spiriva ) Respimat, a once-daily long-acting anticholinergic ...


Once-daily Tiotropium ( Spiriva ) Respimat, a long-acting anticholinergic bronchodilator, has been shown in a phase III program to improve lung function and reduce severe exacerbation risk in severe a ...


Data from phase 3 studies of Tiotropium ( Spiriva ) delivered via the Respimat inhaler in mild, moderate and severe asthma patients were presented at the 2014 American Academy of Allergy, Asthma & ...


Increased arterial stiffness as measured by aortic pulse wave velocity ( aPWV ) predicts cardiovascular events and mortality and is elevated in patients with COPD ( chronic obstructive pulmonary disea ...


Long-acting inhaled bronchodilators, including anticholinergic Tiotropium ( Spiriva ), are recommended for the maintenance therapy of chronic obstructive pulmonary disease ( COPD ). It has been show ...


The role of Tiotropium ( Spiriva ) for the treatment of adolescents with asthma has not yet been clearly defined. A study has assessed the efficacy and safety of inhaled Tiotropium in adolescents with ...